Reverse DCF
Infosys: what the price is assuming
A normal DCF asks you to guess growth. Run backwards, it takes today's price and solves for the growth the market has already priced in — then you can judge whether this company can deliver it.
What the price assumes
AttractiveTo justify its price of ₹1038, this stock must grow earnings at -2% every year for 5 years. Our analysis caps realistic growth at ~3%. At that growth it is worth ₹1333 — upside of 28%.
- Growth the price implies
- -1.8% a year
- for 5 years, fading to 5%
- It has actually compounded at
- Not enough history
- The gap
- -0.0 pp
- 28% downside if it only repeats history
Why this baseline, and what it is built on
Infosys has a generally good promise track record with more achieved/new promises than missed/ghosted. Management provides clear revenue growth guidance of 1.5% to 3.5% for FY27 in constant currency. While recent TTM sales growth has slowed to around 3.16%, the conservative estimate of 3.0% for g1 aligns with the higher end of this guidance, reflecting a cautious but trusting approach to management's forward view. The company maintains very low leverage, supporting a reasonable discount rate of 10%. A 5-year stage-1 growth period is appropriate for a large, established IT services firm, with a 3-year fade to a 5% terminal growth rate.
Through 2026-03-31
Your assumptions
Change any of these and the value moves. A valuation that flips on a one-point change in the required return is telling you something.
Value on these assumptions
₹1,332.35
Against today's price
+28%
8 projected years, then a terminal value at 5.0%.
Normalized net profit is discounted as a proxy for owner earnings, not full free cash flow. An analytical tool, not investment advice.
How to read this valuation
- Start from the price, not the forecast. A normal DCF asks you to guess growth and hands back a fair value. Run backwards, it takes today's price and solves for the earnings growth the market is already assuming.
- Compare that with what the company has done. The historical profit and EPS CAGR sit beside the implied number. A price that needs 25% a year from a business that has compounded at 10% is asking a lot, and the gap is the risk you are taking on.
- Then apply your own view. Change the growth rate, how long it lasts, how it fades and the return you require. A valuation that flips on a one-point change in the discount rate is telling you something about itself.
- Mind the caveats. Normalized net profit stands in for owner earnings, not full free cash flow; terminal growth is capped at 6%, roughly nominal GDP; cyclicals are flagged because a peak-earnings base overstates value. This is an analytical tool, not investment advice.